CBIZ INC (CBZ)

US1248051021 - Common Stock

72.76  -2.77 (-3.67%)

After market: 72.76 0 (0%)

Fundamental Rating

5

Overall CBZ gets a fundamental rating of 5 out of 10. We evaluated CBZ against 81 industry peers in the Professional Services industry. CBZ has an average financial health and profitability rating. CBZ is valied quite expensively at the moment, while it does show a decent growth rate.



6

1. Profitability

1.1 Basic Checks

CBZ had positive earnings in the past year.
In the past year CBZ had a positive cash flow from operations.
CBZ had positive earnings in each of the past 5 years.
In the past 5 years CBZ always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of CBZ (5.92%) is better than 68.75% of its industry peers.
With a decent Return On Equity value of 15.28%, CBZ is doing good in the industry, outperforming 73.75% of the companies in the same industry.
CBZ has a Return On Invested Capital of 8.11%. This is comparable to the rest of the industry: CBZ outperforms 58.75% of its industry peers.
CBZ had an Average Return On Invested Capital over the past 3 years of 7.99%. This is below the industry average of 12.23%.
The last Return On Invested Capital (8.11%) for CBZ is above the 3 year average (7.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.92%
ROE 15.28%
ROIC 8.11%
ROA(3y)5.29%
ROA(5y)5.22%
ROE(3y)13.37%
ROE(5y)12.4%
ROIC(3y)7.99%
ROIC(5y)7.14%

1.3 Margins

CBZ's Profit Margin of 7.60% is fine compared to the rest of the industry. CBZ outperforms 80.00% of its industry peers.
In the last couple of years the Profit Margin of CBZ has grown nicely.
The Operating Margin of CBZ (10.60%) is better than 78.75% of its industry peers.
In the last couple of years the Operating Margin of CBZ has remained more or less at the same level.
With a Gross Margin value of 14.15%, CBZ is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CBZ has remained more or less at the same level.
Industry RankSector Rank
OM 10.6%
PM (TTM) 7.6%
GM 14.15%
OM growth 3Y3.37%
OM growth 5Y1.08%
PM growth 3Y-2.18%
PM growth 5Y2.62%
GM growth 3Y-0.52%
GM growth 5Y-0.19%

6

2. Health

2.1 Basic Checks

CBZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CBZ has been reduced compared to 1 year ago.
CBZ has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CBZ is higher compared to a year ago.

2.2 Solvency

CBZ has an Altman-Z score of 3.44. This indicates that CBZ is financially healthy and has little risk of bankruptcy at the moment.
CBZ has a Altman-Z score of 3.44. This is in the better half of the industry: CBZ outperforms 61.25% of its industry peers.
The Debt to FCF ratio of CBZ is 2.39, which is a good value as it means it would take CBZ, 2.39 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.39, CBZ is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that CBZ is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.39, CBZ is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 2.39
Altman-Z 3.44
ROIC/WACC0.9
WACC8.98%

2.3 Liquidity

A Current Ratio of 1.20 indicates that CBZ should not have too much problems paying its short term obligations.
The Current ratio of CBZ (1.20) is comparable to the rest of the industry.
CBZ has a Quick Ratio of 1.20. This is a normal value and indicates that CBZ is financially healthy and should not expect problems in meeting its short term obligations.
CBZ has a Quick ratio (1.20) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.20% over the past year.
CBZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.90% yearly.
The Revenue has grown by 12.69% in the past year. This is quite good.
CBZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.53% yearly.
EPS 1Y (TTM)20.2%
EPS 3Y19.07%
EPS 5Y16.9%
EPS growth Q2Q-13.04%
Revenue 1Y (TTM)12.69%
Revenue growth 3Y18.19%
Revenue growth 5Y11.53%
Revenue growth Q2Q11.02%

3.2 Future

Based on estimates for the next years, CBZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.51% on average per year.
CBZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.17% yearly.
EPS Next Y15.57%
EPS Next 2Y14.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.13%
Revenue Next 2Y7.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.57 indicates a quite expensive valuation of CBZ.
Based on the Price/Earnings ratio, CBZ is valued a bit more expensive than the industry average as 65.00% of the companies are valued more cheaply.
CBZ is valuated rather expensively when we compare the Price/Earnings ratio to 24.84, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 26.45, which means the current valuation is very expensive for CBZ.
61.25% of the companies in the same industry are cheaper than CBZ, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.35, CBZ is valued a bit more expensive.
Industry RankSector Rank
PE 30.57
Fwd PE 26.45

4.2 Price Multiples

61.25% of the companies in the same industry are cheaper than CBZ, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as CBZ.
Industry RankSector Rank
P/FCF 27.95
EV/EBITDA 19.27

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CBZ does not grow enough to justify the current Price/Earnings ratio.
CBZ has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CBZ's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)1.96
PEG (5Y)1.81
EPS Next 2Y14.51%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBZ!.
Industry RankSector Rank
Dividend Yield N/A

CBIZ INC

NYSE:CBZ (4/26/2024, 7:04:00 PM)

After market: 72.76 0 (0%)

72.76

-2.77 (-3.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.65B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 30.57
Fwd PE 26.45
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.96
PEG (5Y)1.81
Profitability
Industry RankSector Rank
ROA 5.92%
ROE 15.28%
ROCE
ROIC
ROICexc
ROICexgc
OM 10.6%
PM (TTM) 7.6%
GM 14.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)20.2%
EPS 3Y19.07%
EPS 5Y
EPS growth Q2Q
EPS Next Y15.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.69%
Revenue growth 3Y18.19%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y